Difference between revisions of "Prostate-specific antigen"

Prostate-specific antigen (view source)

1,168 bytes added , 16:39, 22 October 2014

48,933

edits

@@ Line 15: / Line 15: @@
 *Abbreviated ''PSAD''.
-Without prostate cancer (normal):<ref name=pmid8998182/>
+*Normal is often consider to be: <0.15 ng/ml.
-*0.19 +/- 0.03 (blacks).
+**Approximately 8% of individuals below the cut-point (0.15 ng/ml) have medium or high-grade cancer.<ref name=pmid12973074>{{Cite journal  | last1 = Boulos | first1 = MT. | last2 = Rifkin | first2 = MD. | last3 = Ross | first3 = J. | title = Should prostate-specific antigen or prostate-specific antigen density be used as the determining factor when deciding which prostates should undergo biopsy during prostate ultrasound. | journal = Ultrasound Q | volume = 17 | issue = 3 | pages = 177-80 | month = Sep | year = 2001 | doi =  | PMID = 12973074 }}
-*0.11 +/- 0.01 (whites).
+</ref>
+**In another series, 48% of individuals with cancer had a PSAD >0.15 ng/ml.<ref name=pmid22482342>{{Cite journal  | last1 = Aganovic | first1 = D. | last2 = Prcic | first2 = A. | last3 = Kulovac | first3 = B. | last4 = Hadziosmanovic | first4 = O. | title = Influence of the prostate volume, prostate specific antigen density and number of biopsy samples on prostate cancer detection. | journal = Med Arh | volume = 66 | issue = 1 | pages = 41-4 | month =  | year = 2012 | doi =  | PMID = 22482342 }}
+</ref>
+Difference between races have been noted; in those without prostate cancer:<ref name=pmid8998182/>
+*0.19 +/- 0.03 ng/ml (blacks).
+*0.11 +/- 0.01 ng/ml (whites).
 Better predictor than (unadjusted) serum PSA for: